T. Rowe Price Associates
INSP icon

T. Rowe Price Associates’s Inspire Medical Systems INSP Stock Holding History

T. Rowe Price Associates’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.48M Sell
167,733
-13,580
-7% -$644K ﹤0.01% 1406
2026
Q1 		$9.35M Sell
181,313
-126,858
-41% -$8.88M ﹤0.01% 1233
2025
Q4 		$28.4M Buy
308,171
+283,243
+1,136% +$27.1M ﹤0.01% 972
2025
Q3 		$1.85M Sell
24,928
-38,710
-61% -$3.92M ﹤0.01% 1764
2025
Q2 		$8.26M Buy
63,638
+7,224
+13% +$1.05M ﹤0.01% 1148
2025
Q1 		$8.99M Sell
56,414
-1,518
-3% -$275K ﹤0.01% 1133
2024
Q4 		$10.7M Sell
57,932
-106,173
-65% -$20.6M ﹤0.01% 1138
2024
Q3 		$34.6M Sell
164,105
-200,766
-55% -$34.9M ﹤0.01% 856
2024
Q2 		$48.8M Sell
364,871
-94,895
-21% -$18M 0.01% 734
2024
Q1 		$98.8M Buy
459,766
+156,893
+52% +$30.8M 0.01% 552
2023
Q4 		$61.6M Buy
302,873
+42,560
+16% +$6.9M 0.01% 644
2023
Q3 		$51.7M Sell
260,313
-56,807
-18% -$14.3M 0.01% 676
2023
Q2 		$103M Buy
317,120
+23,925
+8% +$6.84M 0.01% 519
2023
Q1 		$68.6M Buy
293,195
+24,448
+9% +$6.18M 0.01% 600
2022
Q4 		$67.7M Buy
268,747
+4,081
+2% +$870K 0.01% 580
2022
Q3 		$46.9M Buy
264,666
+25,737
+11% +$5.17M 0.01% 667
2022
Q2 		$43.6M Buy
238,929
+5,338
+2% +$1.06M 0.01% 919
2022
Q1 		$60M Buy
233,591
+2,835
+1% +$648K 0.01% 909
2021
Q4 		$53.1M Buy
230,756
+293
+0.1% +$71.5K ﹤0.01% 984
2021
Q3 		$53.7M Buy
230,463
+147
+0.1% +$30.7K 0.01% 979
2021
Q2 		$44.5M Sell
230,316
-163
-0.1% -$32.3K ﹤0.01% 1067
2021
Q1 		$47.7M Buy
230,479
+59,556
+35% +$12.7M ﹤0.01% 1019
2020
Q4 		$32.1M Buy
170,923
+167,857
+5,475% +$27.4M ﹤0.01% 1093
2020
Q3 		$396K Buy
+3,066
New +$338K ﹤0.01% 2184
2019
Q3 		– Sell
-20,775
Closed -$1.26M – 2534
2019
Q2 		$1.26M Sell
20,775
-684,816
-97% -$36.9M ﹤0.01% 1753
2019
Q1 		$40.1M Buy
705,591
+90,563
+15% +$4.89M 0.01% 959
2018
Q4 		$26M Buy
+615,028
New +$26.1M ﹤0.01% 1065

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates's INSP Position: Q2 2026 in Review

T. Rowe Price Associates reduced its Inspire Medical Systems (INSP) stake by 7.5% in Q2 2026, selling an estimated $644K and leaving 167,733 shares worth $7.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1406.

T. Rowe Price Associates first reported a position in INSP in Q4 2018 and has held it in 27 quarters since. The position peaked at $103M in Q2 2023. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • T. Rowe Price Associates held 167,733 shares of Inspire Medical Systems worth $7.48M as of Q2 2026.
  • T. Rowe Price Associates sold 13,580 Inspire Medical Systems shares in Q2 2026, an estimated $644K.
  • Inspire Medical Systems made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1406 holding.
  • T. Rowe Price Associates first reported a position in Inspire Medical Systems in Q4 2018 and has held it in 27 quarters since.
  • T. Rowe Price Associates's Inspire Medical Systems position peaked at $103M in Q2 2023.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.